Applying Stem Cells to Orthopaedic Conditions

Frank B. Kelly, MD; Mary Ann Porucznik

The ability of stem cells to divide and become more specialized cells—such as bone, blood, or muscle—makes them attractive agents in many areas of medicine. Additionally, the ability to harvest stem cells from an individual and reimplant them in the same individual, thus potentially reducing or eliminating the risk of infection, makes stem cell therapy appealing to both patients and physicians.

The Importance of Sexual Dimorphism Research

Laura M. Bruse Gehrig, MD

Laura M. Bruse Gehrig, MD The AAOS Women’s Health Issues Advisory Board (WHIAB) seeks to advocate, advance, and serve as a resource for research on sex and gender differences in musculoskeletal health for a variety of audiences, including orthopaedic surgeons, policymakers, and the general public. The WHIAB has several ongoing initiatives to promote awareness of sex differences in the diagnosis, treatment, and outcomes of orthopaedic conditions.

Past and Present: HSS and OREF Share a Strong Commitment to Research

Sharon Johnson

Since 1955, when the Orthopaedic Research and Education Foundation (OREF) was formally constituted at New York’s Hospital for Special Surgery (HSS), the HSS orthopaedic surgery faculty has been among its most faithful supporters. That support has come not only from financial contributions, but also from HSS’ tradition of requiring its residents to apply for OREF funding.

Uniform Implant Labeling: A Patient Safety Issue

Kent Jason Lowry, MD; Joe B. Wilkinson, MD; William M. Mihalko, MD, PhD

For more than 5 years, the AAOS Biomedical Engineering Committee has been working with an international standards-setting group (ASTM-International) and multiple other stakeholders to establish uniform labeling standards for orthopaedic implants. Members of the committee, as well as representatives from the U.S.